NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors

被引:47
作者
Regunathan, J
Chen, YH
Wang, DM
Malarkannan, S
机构
[1] Blood Ctr SE Wisconsin Inc, Blood Res Inst, Lab Mol Immunol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Microbiol Mol Genet, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
关键词
D O I
10.1182/blood-2004-03-1075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interaction of the activating ligand H60 with NKG2D receptor constitutes a major stimulatory pathway for natural killer (NK) cells. The influence of inhibitory Ly49 receptors on NKG2D-mediated activation is not clearly understood. Here we show that the magnitude of NKG2D-mediated cytotoxicity is directly proportional to both the levels of H60 and the nature of major histocompatibility complex (MHC) class I molecules expressed on the target cells. The expression levels of H60 on the target cells determined the extent to which the inhibition by Ly49C/I receptors can be overridden. In contrast, even a higher expression of H60 molecule on the target cells failed to overcome the inhibition mediated by Ly49A/G receptors. Also, the level of interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GM-CSF) generated by NK cells through anti-NKG2D monoclonal anti-body (mAb)-mediated activation is significantly reduced by the presence of immobilized anti-Ly49A/G mAbs. Thus, NKG2D-mediated cytotoxicity and cytokine secretion results from the fine balance between activating and inhibitory receptors, thereby defining the NK cell-mediated immune responses. (C) 2005 by The American Society of Hematology.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 45 条
[1]   NK cell activation: Distinct stimulatory pathways counterbalancing inhibitory signals [J].
Bakker, ABH ;
Wu, J ;
Phillips, JH ;
Lanier, LL .
HUMAN IMMUNOLOGY, 2000, 61 (01) :18-27
[2]  
Bennett M, 1995, Semin Immunol, V7, P121, DOI 10.1006/smim.1995.0016
[3]   Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation [J].
Binstadt, BA ;
Brumbaugh, KM ;
Dick, CJ ;
Scharenberg, AM ;
Williams, BL ;
Colonna, M ;
Lanier, LL ;
Kinet, JP ;
Abraham, RT ;
Leibson, PJ .
IMMUNITY, 1996, 5 (06) :629-638
[4]   Cutting edge: Murine UL16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for marine NKG2D [J].
Carayannopoulos, LN ;
Naidenko, OV ;
Fremont, DH ;
Yokoyama, WM .
JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4079-4083
[5]   Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice [J].
Cerwenka, A ;
Bakker, ABH ;
McClanahan, T ;
Wagner, J ;
Wu, J ;
Phillips, JH ;
Lanier, LL .
IMMUNITY, 2000, 12 (06) :721-727
[6]   Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo [J].
Cerwenka, A ;
Baron, JL ;
Lanier, LL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11521-11526
[7]   Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation [J].
Chalifour, A ;
Roger, J ;
Lemieux, S ;
Duplay, P .
IMMUNOLOGY, 2003, 109 (01) :58-67
[8]  
Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4
[9]   Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2Kb [J].
Dam, J ;
Guan, RJ ;
Natarajan, K ;
Dimasi, N ;
Chlewicki, LK ;
Kranz, DM ;
Schuck, P ;
Margulies, DH ;
Mariuzza, RA .
NATURE IMMUNOLOGY, 2003, 4 (12) :1213-1222
[10]   Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages [J].
Diefenbach, A ;
Jamieson, AM ;
Liu, SD ;
Shastri, N ;
Raulet, DH .
NATURE IMMUNOLOGY, 2000, 1 (02) :119-126